Published April 28, 2021 3:38pm Figures today show 31 new COVID-19 cases, no new recovery, and 4 new fatalities among Filipinos abroad. This brings the total number of COVID-19 cases and recoveries among our nationals abroad to 18,301 and 11,220 respectively.@teddyboylocsin#DFAForgingAhead#WeHealAsOnepic.twitter.com/J32mEKZRjy DFA Philippines (@DFAPHL) April 28, 2021 The Department of Foreign Affairs on Wednesday reported 31 new cases of COVID-19 among Filipinos overseas, raising the total tally to 18,301. The death toll rose to 1,145 with four new fatalities, while total recoveries remained at 11,220. So far, there are 5,936 patients undergoing treatment for the disease. The Middle East/Africa still had the highest number of COVID-19-positive Filipinos at 10,443, including 5,893 recoveries and 747 deaths.
DENR to investigate possible oil spill in Manila Bay
Published April 25, 2021 8:54pm The Department of Environment and Natural Resources is investigating a possible oil spill in Manila Bay. According to a report on 24 Oras Weekend on Sunday, yellow stains can be seen in the water surrounding a yacht moored beside the sea wall of the Manila Yacht Club. The DENR said the possible oil spill spread about 500 meters. The DENR took samples of the water which were sent to the Environmental Management Bureau to determine if it was oil. The water has yet to be cleaned by authorities. Ma. Angelica Garcia/DVM, GMA News
The Department of Foreign Affairs on Wednesday reported five new cases of the coronavirus disease 2019 (COVID-19) among Filipinos overseas, bringing the total to 18,165.
20M Moderna vaccine doses from US face delay, says envoy
Published April 15, 2021 8:45pm Some 20 million doses of American pharmaceutical firm Moderna s COVID-19 vaccine, which are expected to arrive in the Philippines in late May, might be slightly delayed, Philippine Ambassador to the United States Jose Manuel Romualdez said. According to Sandra Aguinaldo’s report on “24 Oras,” Romualdez said the delay is due to the United State’s policy on vaccine export. “There’s sort of like a ban for exporting these vaccines coming from the United States because of the domestic demand,” Romualdez said. He added that the recent pause in the use of Johnson & Johnson’s COVID-19 vaccine in the US also resulted in the setback.